Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy.
D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008140:Lorazepam / Q000008:administration & dosage*; D009325:Nausea / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000517:prevention & control*
D014151:Anti-Anxiety Agents; D000970:Antineoplastic Agents; D008140:Lorazepam